Clinical Trials Browser

Has results × Recurrence × Fibroblast Growth Factor 7 × Clear all

NCT01200329 2019-12-16

High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease

Phase 2 Completed

81 enrolled 8 charts

Hodgkin Disease, Lymphoma, Recurrence